Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Parkinson Disease × Neuropsychological Tests × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 12 Cognitive Dysfunction 4 Radiation Injuries 3 Neoplasms 3 Glioma 3 Multiple Myeloma 2 Lymphoma, B-Cell 2 Glioblastoma 2 Fatigue 2 Breast Neoplasms 2 Astrocytoma 2 Triple Negative Breast Neoplasms 1 Stroke 1 Sarcoma 1 Pituitary Neoplasms 1 Parkinson Disease 1 Osteosarcoma 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Neoplasm Metastasis 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Localized, Operable Non-small Cell Lung Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Hodgkin Disease 1

Interventions

fluorodopa F 18 2 Registries 1 Positron Emission Tomography Computed Tomography 1 Neuropsychological Tests 1 Neurofeedback 1 Furosemide 1 Exergaming 1 4-chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05791006 2023-03-30

NEUROFIN

Istituto Auxologico Italiano

Brain Neoplasms, Parkinson Disease, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon ⚡